Research Interest:  Drug Delivery, Pharmacokinetics, Controlled Release, Drug Targeting, Prodrug

Research Interest: Gentics; Tree Genetic Improvement; Plant Biotechlology

Research Interest: Biological activity of blood platelets; inflammatory properties of platelets; interaction of blood platelets with the cells of the immune system; autoimmune diseases; activation and platelet reactivity in neurodegenerative diseases (multiple sclerosis); proteome, transcriptome and metabolome of platelets; molecular markers of platelets in the diagnosis of acute coronary syndromes

Research Interest:  pharmacological approaches in human ex vivo / in vitro models targeted against inflammation&proliferation&migration in atherosclerosis and restenosis following angioplasty.

Research Interest: With a combination of molecular biology, biochemistry, cell biology, nutrition metabolism,transgenic/knockout mice model, I aim to uncover the complex molecular programs that regulates physiological or pathological biological pathways, such as cell commitment, cell metabolism, embryonic development, brain development, nutrition regulation, and the pathological mechanisms of human metabolic diseases, such as obesity, diabetes and neurological disease..

Research Interest: Methodology of solid phase peptide synthesis and synthetic peptides with bioactivity

Research Interest: Studying the pathogenic process in betanodavirus and iridovirus infection in grouper GF-1 and larval grouper fish systems. His laboratory pioneered the use of grouper model to study betanodavirus in vivo on brain damaged, which as a model. 

Research Interest:  Obesity, metabolic syndrome, diabetes type 2,dyslipidemia,hypertension.

Research Interest:  Phosphate-based glass production and characterisation including Phosphate glass-fibre (PGF) production. He is also currently working on resorbable polymer composites, mainly for bone repair applications. His other interests include, calcium phosphate cements, microsphere technologies, drug delivery systems, Tissue Engineering and Regenerative Medicine applications

Research Interest: Aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr. Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetes and diabetic osteoporosis, cancer biology, and cancer bone metastasis. Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001) in mammalian cells. Dr. Yamaguchi generated regucalcin transgenic rats, which were registered as international patents (USA, EU, Japan, and Korea), and this animal was found to induce osteoporosis and hyperlipidemia. Moreover, Dr. Yamaguchi proposed the potential role of regucalcin as a key suppressor protein in carcinogenesis.  Currently, the research of regucalcin is focused as a scientific topic 

Research Interest:  Neurogenesis. Screening the leading chemical to stimulate the neurogenesis after CNS, diseases, including: Stroke, Multiple sclerosis, Alzheimers disease et al.  Brain tumor. To study the oncogenesis mechanisms of mellablastoma and glioblastoma.At the same time, to screen the inhibitor of Sonic hedgehog pathway to treat the brain tumor.

Research Interest:  Fungal biotechnology, Marine bacterial phylogenetics and taxonomy

Research Interest: Pharmacology/Toxicology Isolation and Identification of Natural products, Drug Discovery and Development, Cellular and Molecular Biology of Diseases 

Research Interest: Polyhydroxyalkanoates (PHAs), bioprocess engineering, biopolymer fermentation, biogas, environmental biotechnology, and environmental microbiology

Research Interest: To explore the molecular biology and their use in genetic toxicology. currently held to identify the genetic research hazard of chemicals, physical and biological